Turecek PL - Search Results

1

Issues complicating precision dosing for factor VIII prophylaxis.

Valentino LA, Turecek PL, Gritsch H, Butenas S, Mann KG. Valentino LA, et al. Among authors: turecek pl. Transfus Apher Sci. 2018 Aug;57(4):472-479. doi: 10.1016/j.transci.2018.07.007. Epub 2018 Aug 21. Transfus Apher Sci. 2018. PMID: 30139569 Free article. Review.

2

Assessment of bleeding for the evaluation of therapeutic preparations in small animal models of antibody-induced hemophilia and von Willebrand disease.

Turecek PL, Gritsch H, Richter G, Auer W, Pichler L, Schwarz HP. Turecek PL, et al. Thromb Haemost. 1997 Mar;77(3):591-9. Thromb Haemost. 1997. PMID: 9066015

3

In vivo characterization of recombinant von Willebrand factor in dogs with von Willebrand disease.

Turecek PL, Gritsch H, Pichler L, Auer W, Fischer B, Mitterer A, Mundt W, Schlokat U, Dorner F, Brinkman HJ, van Mourik JA, Schwarz HP. Turecek PL, et al. Blood. 1997 Nov 1;90(9):3555-67. Blood. 1997. PMID: 9345039 Free article.

4

Continuous infusion of FVIII and FIX concentrates: in vitro analysis of clinically relevant parameters.

Thomas KB, Urbancik W, Turecek PL, Gritsch H, Schreiber J, Weber A, Schönhofer W, Strauss M, Linnau Y, Schoppmann A. Thomas KB, et al. Among authors: turecek pl. Haemophilia. 1999 Jan;5(1):17-25. doi: 10.1046/j.1365-2516.1999.00210.x. Haemophilia. 1999. PMID: 10215943 Clinical Trial.

5

Factor Xa and prothrombin: mechanism of action of FEIBA.

Turecek PL, Varadi K, Gritsch H, Auer W, Pichler L, Eder G, Schwarz HP. Turecek PL, et al. Vox Sang. 1999;77 Suppl 1:72-9. doi: 10.1159/000056722. Vox Sang. 1999. PMID: 10529694

6

Phenotypic expression of murine hemophilia.

Muchitsch EM, Turecek PL, Zimmermann K, Pichler L, Auer W, Richter G, Gritsch H, Schwarz HP. Muchitsch EM, et al. Among authors: turecek pl. Thromb Haemost. 1999 Oct;82(4):1371-3. Thromb Haemost. 1999. PMID: 10544939 No abstract available.

7

Recombinant von Willebrand factor: preclinical development.

Plaimauer B, Schlokat U, Turecek PL, Mitterer A, Mundt W, Auer W, Pichler L, Gritsch H, Schwarz HP. Plaimauer B, et al. Among authors: turecek pl. Semin Thromb Hemost. 2001 Aug;27(4):395-403. doi: 10.1055/s-2001-16892. Semin Thromb Hemost. 2001. PMID: 11547362 Review.

8

Single cell analysis of factor VIII-specific T cells in hemophilic mice after treatment with human factor VIII.

Sasgary M, Ahmad RU, Schwarz HP, Turecek PL, Reipert BM. Sasgary M, et al. Among authors: turecek pl. Thromb Haemost. 2002 Feb;87(2):266-72. Thromb Haemost. 2002. PMID: 11858486

9

Recombinant von Willebrand factor-insight into structure and function through infusion studies in animals with severe von Willebrand disease.

Schwarz HP, Schlokat U, Mitterer A, Váradi K, Gritsch H, Muchitsch EM, Auer W, Pichler L, Dorner F, Turecek PL. Schwarz HP, et al. Among authors: turecek pl. Semin Thromb Hemost. 2002 Apr;28(2):215-26. doi: 10.1055/s-2002-27823. Semin Thromb Hemost. 2002. PMID: 11992244

10

Factor VIII inhibitor-bypassing agents act by inducing thrombin generation and can be monitored by a thrombin generation assay.

Turecek PL, Váradi K, Keil B, Negrier C, Berntorp E, Astermark J, Bordet JC, Morfini M, Linari S, Schwarz HP. Turecek PL, et al. Pathophysiol Haemost Thromb. 2003;33(1):16-22. doi: 10.1159/000071637. Pathophysiol Haemost Thromb. 2003. PMID: 12853708 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

131 results

Search Page